Syros Pharmaceuticals Inc (OQ:SYRS)

Business Focus: Biotechnology & Medical Research

Sector:  Healthcare Industry:  Biotechnology & Medical Research
 
See Regulatory Filings on SEC
Company Contact
Address: 35 Cambridge Park Drive
CAMBRIDGE MA 02140
Tel: N/A
Website: https://syros.com
IR: See website
<
Key People
Conley Chee
President, Chief Executive Officer, Director
Jason Haas
Chief Financial Officer
Gerald E. Quirk
Chief Legal Officer
David A. Roth
Chief Medical Officer
Kristin Stephens
Chief Development Officer
 
Business Overview
N/A
Financial Overview
For the fiscal year ended 31 December 2023, Syros Pharmaceuticals Inc revenues decreased 33% to $9.9M. Net loss increased 74% to $164.6M. Revenues reflect a decrease in demand for the Company's products and services due to unfavorable market conditions. Higher net loss reflects FV Adjustments of Financial Investments decrease from $43.2M (income) to $37.3M (expense), Research & Development - Balancing value increase of 1% to $76.7M (expense).
Employees: 68 as of Dec 31, 2023
Reporting Currency: U.S. Dollars
Enterprise value: $38.98M as of Dec 31, 2023
Annual revenue (TTM): $9.94M as of Dec 31, 2023
EBITDA (TTM): -$124.25M as of Dec 31, 2023
Net annual income (TTM): -$164.57M as of Dec 31, 2023
Free cash flow (TTM): -$109.98M as of Dec 31, 2023
Net Debt Last Fiscal Year: N/A
Shares outstanding: 26,453,891 as of Mar 6, 2024
TTM: Trailing Twelve Months
EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please log in or subscribe.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.